BioElectronics' ActiPatch cleared in Australia

BioElectronics Corp says that the Australian Therapeutic Goods Administration has cleared ActiPatch for sale by its distributor, local firm Endotherapeutics. The product is a drug-free, anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy to reduce soft tissue pain and swelling for less than one dollar a day

Ivan Srejber, managing director of Endotherapeutics, said: "we have extensive experience in launching products and establishing significant market share for previously unknown products. We are very excited about the market potential for ActiPatch in Australia and look forward to a mutually beneficial business partnership with BioElectronics Corporation."

Founded in 1998, Endotherapeutics has provided medical technologies for the health care specialist throughout Australia. Companies represented by Endotherapeutics are leaders in their specific market segments, BioElectronics noted.